In recent years, artificial intelligence (AI) or machine learning (ML) methods have been increasingly used in the development and evaluation of clinical prediction models. Their algorithms differ from traditional regression modeling methods, resulting in significant limitations of the existing Prediction Model Risk of Bias Assessment Tool (PROBAST) for their evaluation. To address these limitations, the tool is updated to PROBAST+AI in 2025. PROBAST+AI extends the original framework to specifically address methodological challenges unique to developing or evaluating clinical prediction models based on AI/ML algorithms. PROBAST+AI assesses the quality of model development and the risk of bias in model evaluation across 4 domains: participants and data sources, predictors, outcome, and analysis, encompassing 16 and 18 signaling questions, respectively. Furthermore, the tool evaluates the applicability of the model across 3 domains: participants and data sources, predictors, and outcome. This article aims to compare the changes between the original and updated versions of the PROBAST tool, interpret the key content and items of PROBAST+AI, and apply the updated tool to evaluate an example clinical prediction model publication, to help domestic systematic review authors, clinicians, and policymakers critically appraise studies that develop or evaluate prediction models based on traditional or AI/ML methods.
HomeArticlesVol 36,2026 No.7Detail
PROBAST+AI: an interpretation of the tool for assessing the quality, risk of bias and applicability of prediction models based on traditional or artificial intelligence methods
Published on Aug. 04, 2026Total Views: 55 timesTotal Downloads: 12 timesDownloadMobile
- Abstract
- Full-text
- References
Abstract
Full-text
References
1. DamenJAAG, HooftL, SchuitE, et al. Prediction models for cardiovascular disease risk in the general population: systematic review[J]. BMJ, 2016, 353: i2416. doi:10.1136/bmj.i2416
2. BellouV, BelbasisL, KonstantinidisAK, et al. Prognostic models for outcome prediction in patients with chronic obstructive pulmonary disease: systematic review and critical appraisal[J]. BMJ, 2019, 367: l5358. doi:10.1136/bmj.l5358
3. de MunterL, PolinderS, LansinkKW, et al. Mortality prediction models in the general trauma population: a systematic review[J]. Injury, 2017, 48(2): 221-229. doi:10.1016/j.injury.2016.12.009
4. WynantsL, Van CalsterB, CollinsGS, et al. Prediction models for diagnosis and prognosis of COVID-19: systematic review and critical appraisal[J]. BMJ, 2020, 369: m1328.
5. Seyyed-KalantariL, ZhangH, McDermottMBA, et al. Underdiagnosis bias of artificial intelligence algorithms applied to chest radiographs in under-served patient populations[J]. Nat Med, 2021, 27(12): 2176-2182. doi:10.1038/s41591-021-01595-0
6. YangY, ZhangH, GichoyaJW, et al. The limits of fair medical imaging AI in real-world generalization[J]. Nat Med, 2024, 30(10): 2838-2848. doi:10.1038/s41591-024-03113-4
7. WolffRF, MoonsKGM, RileyRD, et al. PROBAST: a tool to assess the risk of bias and applicability of prediction model studies[J]. Ann Intern Med, 2019, 170(1): 51-58. doi:10.7326/m18-1376
8. SchinkelM, ParanjapeK, Nannan PandayRS, et al. Clinical applications of artificial intelligence in sepsis: a narrative review[J]. Comput Biol Med, 2019, 115: 103488. doi:10.1016/j.compbiomed.2019.103488
9. HurkmansC, BibaultJE, ClementelE, et al. Assessment of bias in scoring of AI-based radiotherapy segmentation and planning studies using modified TRIPOD and PROBAST guidelines as an example[J]. Radiother Oncol, 2024, 194: 110196. doi:10.1016/j.radonc.2024.110196
10. CaiY, CaiYQ, TangLY, et al. Artificial intelligence in the risk prediction models of cardiovascular disease and development of an independent validation screening tool: a systematic review[J]. BMC Med, 2024, 22(1): 56. doi:10.1186/s12916-024-03273-7
11. KaulT, DamenJA, WynantsL, et al. Assessing the quality of prediction models in healthcare using the Prediction Model Risk of Bias Assessment Tool (PROBAST): an evaluation of its use and practical application[J]. J Clin Epidemiol, 2025, 181: 111732. doi:10.1016/j.jclinepi.2025.111732
12. MoonsKGM, DamenJAA, KaulT, et al. PROBAST+AI: an updated quality, risk of bias, and applicability assessment tool for prediction models using regression or artificial intelligence methods[J]. BMJ, 2025, 388: e082505. doi:10.1136/bmj-2024-082505
13. FinlaysonSG, BeamAL, van SmedenM. Machine learning and statistics in clinical research articles-moving past the false dichotomy[J]. JAMA Pediatr, 2023, 177(5): 448-450. doi:10.1001/jamapediatrics.2023.0034
14. HigginsJPT, ThomasJ, ChandlerJ, et al. Cochrane handbook for systematic reviews of interventions version 6.5 (updated August 2024)[M]. Cochrane: Cochrane Collaboration, 2024.
15. BurdickH, PinoE, Gabel-ComeauD, et al. Validation of a machine learning algorithm for early severe sepsis prediction: a retrospective study predicting severe sepsis up to 48 h in advance using a diverse dataset from 461 US hospitals[J]. BMC Med Inform Decis Mak, 2020, 20(1): 276. doi:10.1186/s12911-020-01284-x
16. 刘俊平. 诊断试验偏倚来源的研究进展[J]. 中国循证医学杂志, 2011, 11(7): 835-840.LiuJP. Advances in research on bias sources in diagnostic test[J]. Chinese Journal of Evidence-Based Medicine, 2011, 11(7): 835-840.
17. RileyRD, SnellKI, EnsorJ, et al. Minimum sample size for developing a multivariable prediction model: part II-binary and time-to-event outcomes[J]. Stat Med, 2019, 38(7): 1276-1296. doi:10.1002/sim.7992
18. RileyRD, SnellKIE, EnsorJ, et al. Minimum sample size for developing a multivariable prediction model: part I-continuous outcomes[J]. Stat Med, 2019, 38(7): 1262-1275. doi:10.1002/sim.7993
19. RileyRD, EnsorJ, SnellKIE, et al. Calculating the sample size required for developing a clinical prediction model[J]. BMJ, 2020, 368: m441. doi:10.1136/bmj.m441
20. MoonsKGM, WolffRF, RileyRD, et al. PROBAST: a tool to assess risk of bias and applicability of prediction model studies: explanation and elaboration[J]. Ann Intern Med, 2019, 170(1): W1-W33. doi:10.7326/m18-1377
21. MäenpääSM, KorjaM. Diagnostic test accuracy of externally validated convolutional neural network (CNN) artificial intelligence (AI) models for emergency head CT scans-a systematic review[J]. Int J Med Inform, 2024, 189: 105523. doi:10.1016/j.ijmedinf.2024.105523
22. ElahmediM, SawhneyR, GuadagnoE, et al. The state of artificial intelligence in pediatric surgery: a systematic review[J]. J Pediatr Surg, 2024, 59(5): 774-782. doi:10.1016/j.jpedsurg.2024.01.044
23. Carrasco-RibellesLA, Llanes-JuradoJ, Gallego-MollC, et al. Prediction models using artificial intelligence and longitudinal data from electronic health records: a systematic methodological review[J]. J Am Med Inform Assoc, 2023, 30(12): 2072-2082. doi:10.1093/jamia/ocad168
24. GanapathiS, PalmerJ, AldermanJE, et al. Tackling bias in AI health datasets through the STANDING together initiative[J]. Nat Med, 2022, 28(11): 2232-2233. doi:10.1038/s41591-022-01987-w
25. CollinsGS, ReitsmaJB, AltmanDG, et al. Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement[J]. BMJ, 2015, 350: g7594. doi:10.1111/eci.12376
26. CollinsGS, MoonsKGM, DhimanP, et al. TRIPOD+AI statement: updated guidance for reporting clinical prediction models that use regression or machine learning methods[J]. BMJ, 2024, 385: e078378. doi:10.1136/bmj.q902
Popular Papers
-
Research on living clinical practice guidelines in diabetes mellitus II: summary of key evidence in the development of drug treatment strategies for type 2 diabetes mellitus
Mar. 05, 20266110
-
Expert consensus on the management of risk factors for benign prostatic hyperplasia (2025 edition)
Apr. 01, 20265567
-
Malnutrition risk prediction models in patients with chronic heart failure: a systematic review and Meta-analysis
Mar. 05, 20264981
-
Research progress on granulosa cell apoptosis in premature ovarian failure
Mar. 05, 20264889
-
Ultrasound features of 33 cases of histiocytic necrotizing lymphadenitis in children
Mar. 05, 20264294
-
A qualitative study on the experience of prostate cancer patients participating in discharge preparation services after surgery based on Meleis' transition theory
Mar. 05, 20264155
-
Cardiovascular disease burden attributed to high low-density lipoprotein cho-lesterol in China from 1990 to 2021 and trend prediction
Mar. 05, 20264075
-
Causal relationships between gut microbiota and blood metabolites in functional dyspepsia: a mediation Mendelian randomization study
Mar. 05, 20263953
-
Investigation on emergency medical rescue nursing ability and nursing training needs of nursing staff in compact county-level medical community
Mar. 05, 20263884
-
The mechanism and clinical application of ferroptosis in head and neck cancer
Mar. 05, 20263871
-
Study on the association between triglyceride-glucose index and osteoarthritis based on NHANES
Mar. 05, 20263837
-
Recurrence rate and influencing factors of benign paroxy-smal positional vertigo after repositioning of otolith: a Meta-analysis
Apr. 30, 20263701
-
Impact of preoperative biliary drainage on postoperative complications in patients with malignant obstructive jaundice: an updated Meta-analysis
Mar. 05, 20263656
-
Role and mechanism of RGS14 in improving acute myocardial infarction by inhibiting TAK1 activation
Mar. 05, 20263617
-
The predictive value of AI-based retinal images model for diabetic retinopathy
Apr. 01, 20263546
Welcome to visit Zhongnan Medical Journal Press Series journal website!